Filter By Industry
Filter By Tag

Newsroom

BioVision, Inc. Press releases

1 - 10 of 257 Press Releases

Jul 22, 2020
A simple, sensitive, robust assay for the quantification of carbohydrates even when present in low concentration.

Jul 21, 2020
For the measurement of Sialyltransferase activity using a 96-well plate format

Jun 24, 2020
Sensitive method for monitoring GAPDH activity in various sample types

Jun 18, 2020
To measure Hydroxyurea (HU) concentrations in human serum or plasma.

Jun 17, 2020
For the quantitation of N-Acetylcysteine in biological samples.

May 28, 2020
To monitor total β-Mannosidase activity in various biological samples

May 21, 2020
Sensitive method to detect CD38 activity in a variety of sample types.

May 20, 2020
For conjugating hapten molecules to Activated KLH carrier protein

May 18, 2020
. AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.

May 06, 2020
AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a first-in-class COVID-19 vaccine candidate (AVI-205) with an active targeting feature, powered by its patented ImmunoBuster-IITM Active Targeting...


Page: 1 2 3 4 5 Next
BioVision, Inc. RSS Feed